dysmenorrhoea where the maximum daily dose is 500 milligrams mefanamic acid 3 times a day and the
maximum treatment period is 3 days. (S2)
Meloxicam.
Mepindolol.
Mesalazine (5-aminosalicylic acid).
Mesulphene.
Metaproterenol (orciprenaline), when contained in respirator solutions. (S2, S4)
Metformin.
Methazolamide.
Methimazole.
Methsuximide.
Methyldopa.
Metipranolol.
Metolazone.
Metoprolol.
Mibefradil.
Moexipril.
Montelukast.
Moxonidine.
Nabumetone, except when intended for the treatment of post-traumatic conditions such as pain, swelling
and inflammation, for a maximum period of 5 days. (S2)
Nadolol.
Naftidrofuryl.
Naproxen, except—
(a)
when intended for application to the skin; (S1)
(b)
the sodium salt, when intended for the short term management of headache,
toothache, muscular ache, backache, minor pain associated with arthritis, pain associated with
menstrual cramps (dysmenorrhoea), minor aches and pains associated with the common cold and
fever, at a maximum dose of 600 milligrams naproxen (660 milligrams naproxen sodium) in 24 hours;
(S2)
(c)
when supplied by a pharmacist to a patient and intended for the emergency treatment
of acute gout attacks or for the treatment of post traumatic conditions such as pain, swelling and
inflammation, for a maximum period of 5 days. (S2)
Nateglinide.
Nebivolol.
Nicardipine.
Nifedipine.
Niflumic acid.
Nimesulide.
Nimodipine.
Nisoldipine.
Nitrendipine.
Nitroglycerine, when intended for medicinal use.
Olsalazine.
Orlistat.
Oxaprozin.
Oxcarbazepine.
Oxitracetam.
Oxovinca.
Oxyprenolol.
Oxybutynin.
Parecoxib.
Para-aminosalicylic acid and its esters.
Penbutolol.
Penicillinase, when intended for injection.
Pentaerythritol tetranitrate.
Pentolinium.
Pentosan polysulfate sodium, when intended for the treatment of interstitial cystitis. (S1)
Perindopril.
Phenformin.
Phenobarbital, preparations and mixtures containing not more than 90 milligrams of phenobarbital per
minimum recommended or prescribed dose when intended for continued use in epilepsy. (S5)
Phenoxymethylpenicillin, when intended for the prophylaxis of rheumatic fever. (S4)
Phentolamine.
Phenytoin.
Physostigmine; ophthalmic preparations thereof, when intended for glaucoma. (S4)
Pilocarpine; ophthalmic preparations thereof intended for glaucoma. (S4)